(Q32020776)

5 July 2017

The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position (English)

1 reference

5 July 2017

J I Levin

1

1 reference

5 July 2017

M T Du

2

1 reference

5 July 2017

J F DiJoseph

3

1 reference

5 July 2017

L M Killar

4

1 reference

5 July 2017

A Sung

5

1 reference

5 July 2017

T Walter

6

1 reference

5 July 2017

M A Sharr

7

1 reference

5 July 2017

C E Roth

8

1 reference

5 July 2017

F J Moy

9

1 reference

5 July 2017

R Powers

10

1 reference

5 July 2017

G Jin

11

1 reference

5 July 2017

R Cowling

12

1 reference

5 July 2017

J S Skotnicki

13

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

5 July 2017

1 reference

5 July 2017

11

1 reference

5 July 2017

2

1 reference

5 July 2017

235-238

1 reference

Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Matrix metalloproteinase inhibitors in arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Matrix metalloproteinase inhibitors: applications in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Design and synthesis of piperazine-based matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

The synthesis and biological activity of a novel series of diazepine MMP inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Spectrophotometric assay for vertebrate collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

A novel in vivo model for the study of cartilage degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900642-9

7 January 2021

10.1016/S0960-894X(00)00642-9

Identifiers

DOI

1 reference

5 July 2017

1 reference